Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture

Osteoporosis International

Volumn 22, Issue 6, 2011, Pages 1799-1808

  Majumdar, S R ^a,d   Lier, D A ^b   Rowe, B H ^a   Russell, A S ^a   McAlister, F A ^a   Maksymowych, W P ^a   Hanley, D A ^c   Morrish, D W ^a   Johnson, J A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Economic analysis; Osteoporosis treatment; Quality improvement; Randomized trial

Indexed keywords

ALENDRONIC ACID;

ADULT; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HIP FRACTURE; HOME CARE; HUMAN; INTERVENTION STUDY; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIFACETED QUALITY IMPROVEMENT INTERVENTION; OSTEOPOROSIS; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SPINE FRACTURE; TOTAL QUALITY MANAGEMENT; UNSPECIFIED SIDE EFFECT; VERTEBRA FRACTURE; WRIST FRACTURE;

EID: 85027928496     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1412-1     Document Type: Conference Paper

References (35)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis related fractures in the United States, 2005-2025. J Bone Miner Res 22:465-475 (Pubitemid 46797130)
2. National Osteoporosis Foundation (2008) Clinicians' guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/professionals/ NOF-Clinicians-Guide.pdf/. Accessed 14 August 2010)
3. Scientific Advisory Council, Osteoporosis Society of Canada (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(suppl):S1-S34
4. Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178(5):569-575 (Pubitemid 351414004)
5. Majumdar SR, Johnson JA, Lier DA et al (2007) Persistence reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18:261-270 (Pubitemid 46233171)
6. Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG et al (2009) Osteoporosis case-manager for hip fracture patients: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169(1):25-31
7. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BR, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366-373
8. Bessette L, Ste-Marie LG, Jean S, Davison KS, Beaulieu M et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79-86 (Pubitemid 350198056)
9. Sonnenberg F, Beck R (1993) Markov models in Medical Decisionmaking: a practical guide. Med Decis Mak 13(4):322-338 (Pubitemid 24013155)
10. Tosteson AN, Jonsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD (2001) Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12:849-857 (Pubitemid 33086272)
11. Johnell O, Jšnsson B, Jšnsson L, Black D (2003) Cost effectiveness of alendronate for the treatment of osteoporosis and prevention of fractures. PharmacoEconomics 21:305-314 (Pubitemid 36403435)
12. Zethraeus N, Borgstršm F, Stršm O, Kanis J, Jšnsson B (2007) Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 18:9-23 (Pubitemid 44885492)
13. Strom O, Zethraeus N, Borgstršm F, Johnell O, Jšnsson B, Kanis J. IOF cost-effectiveness reference model: background document. International Osteoporosis Foundation. Available at: http://www.iofbonehealth. org. Accessed 5 March 2010
14. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739 (Pubitemid 30174026)
15. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271-278 (Pubitemid 34912733)
16. Cranney A, Guyatt GH, Griffith L, Wells G, Tugwell P, for the Osteoporosis Research Advisory Group (2002) IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocrinol Rev 23:570-578 (Pubitemid 34925651)
17. Tonino RP, Meunier PJ, Emkey RD, Rodriguez-Portales JA, Menkes CJ, Wasnich RD et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109-3115
18. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD et al (2004) Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189-1199 (Pubitemid 38339363)
19. Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM et al (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414-2419 (Pubitemid 41640855)
20. Schousboe JT, Nyman JA, Kane RL, Ensrud KE (2005) Costeffectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142:734-741 (Pubitemid 40593775)
21. Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, et al (2010) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int doi: 10.1007/s00198-010-1212-7
22. Alberta Health Care Insurance Plan (2006) Schedule of medical benefits (procedures and price list). Alberta Health Care, Edmonton, Alberta, Canada
23. Alberta Health and Wellness (2007) Drug benefits list. Alberta Health and Wellness, Edmonton, Alberta, Canada
24. Alberta Health and Wellness (2006) Health Costing in Alberta - Annual Report. Edmonton, Alberta, Canada
25. Canadian Institute for Health Information (2006) Resource intensity weights and expected length of stay. Canadian Institute for Health Information, Ottawa, Ontario, Canada
26. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7:221-227
27. Statistics Canada (2006) Life tables-Canada, provinces and territories, 2000-2002 (84-537-XIE). Statistics Canada, Ottawa, Ontario, Canada
28. Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of health state utility values for osteoporosis related conditions. Osteoporos Int 20:853-868
29. Koopmanschap MA, Rutten FFH (1996) A practical guide for calculating indirect costs of disease. PharmacoEconomics 10(5):460-466 (Pubitemid 26359874)
30. Statistics Canada (2009) Labour force survey estimates (LFS)-wages of employees by type of work, National Occupational Classification for Statistics (NOC-S), sex and age group, unadjusted for seasonality, computed annual average (Table 282-0069). Statistics Canada, Ottawa, Ontario, Canada
31. Dong H, Buxton M (2006) Early assessment of the likely costeffectiveness of a new technology: a Markov model with probabilistic sensitivity analysis of computer-assisted knee replacement. Int J Technol Assess Health Care 22:191-202
32. Donaldson C, Currie G, Mitton C (2002) Cost-effectiveness analysis in healthcare: contraindications. BMJ 325:891-894
33. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799-1809 (Pubitemid 350044800)
34. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V et al (2008) Systematic review: comparative effectiveness of treatments to prevent fracture in men and women with low bone density or osteoporosis. Ann Intern Med 148:197-213 (Pubitemid 351665507)
35. Majumdar SR (2008) Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheum 35:190-193